HEADER HYDROLASE 10-MAR-08 3CHR TITLE CRYSTAL STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH 4-AMINO- TITLE 2 N-[4-(PHENYLMETHOXY)PHENYL]-BUTANAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUKOTRIENE A-4 HYDROLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LTA-4 HYDROLASE, LEUKOTRIENE A(4) HYDROLASE; COMPND 5 EC: 3.3.2.6; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LTA4H, LTA4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: JM101; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT3-MB4 KEYWDS EPOXIDE HYDROLASE, ALPHA-BETA PROTEIN, LEUKOTRIENE BIOSYNTHESIS, KEYWDS 2 METALLOPROTEASE, INHIBITOR COMPLEX, ALTERNATIVE SPLICING, CYTOPLASM, KEYWDS 3 METAL-BINDING, MULTIFUNCTIONAL ENZYME, ZINC, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.M.G.M.THUNNISSEN,M.ADLER,M.WHITLOW REVDAT 6 21-FEB-24 3CHR 1 REMARK LINK REVDAT 5 24-JUL-19 3CHR 1 REMARK REVDAT 4 07-MAR-18 3CHR 1 REMARK REVDAT 3 24-FEB-09 3CHR 1 VERSN REVDAT 2 27-MAY-08 3CHR 1 JRNL REVDAT 1 22-APR-08 3CHR 0 JRNL AUTH T.A.KIRKLAND,M.ADLER,J.G.BAUMAN,M.CHEN,J.Z.HAEGGSTROM, JRNL AUTH 2 B.KING,M.J.KOCHANNY,A.M.LIANG,L.MENDOZA,G.B.PHILLIPS, JRNL AUTH 3 M.THUNNISSEN,L.TRINH,M.WHITLOW,B.YE,H.YE,J.PARKINSON, JRNL AUTH 4 W.J.GUILFORD JRNL TITL SYNTHESIS OF GLUTAMIC ACID ANALOGS AS POTENT INHIBITORS OF JRNL TITL 2 LEUKOTRIENE A4 HYDROLASE. JRNL REF BIOORG.MED.CHEM. V. 16 4963 2008 JRNL REFN ISSN 0968-0896 JRNL PMID 18394906 JRNL DOI 10.1016/J.BMC.2008.03.042 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.M.G.M.THUNNISSEN,P.N.NORDLUND,J.Z.HAEGGSTROM REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN LEUKOTRIENE A4 HYDROLASE, A REMARK 1 TITL 2 BIFUNCTIONAL ENZYME IN INFLAMMATION REMARK 1 REF NAT.STRUCT.BIOL. V. 8 131 2001 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.M.G.M.THUNNISSEN,B.ANDERSON,B.SAMUELSSON,C.-H.WONG, REMARK 1 AUTH 2 J.Z.HAEGGSTROM REMARK 1 TITL CRYSTAL STRUCTURES OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX REMARK 1 TITL 2 WITH CAPTOPRIL AND TWO COMPETITIVE TIGHT-BINDING INHIBITORS. REMARK 1 REF FASEB J. V. 16 1648 2002 REMARK 1 REFN ISSN 0892-6638 REMARK 1 REFERENCE 3 REMARK 1 AUTH P.C.RUDBERG,F.THOLANDER,M.M.THUNNISSEN,B.SAMUELSSON, REMARK 1 AUTH 2 J.Z.HAEGGSTROM REMARK 1 TITL LEUKOTRIENE A4 HYDROLASE: SELECTIVE ABROGATION OF REMARK 1 TITL 2 LEUKOTRIENE B4 FORMATION BY MUTATION OF ASPARTIC ACID 375. REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 99 4215 2002 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 4 REMARK 1 AUTH P.C.RUDBERG,F.O.T.THOLANDER,M.ANDBERG,M.M.G.M.THUNNISSEN, REMARK 1 AUTH 2 J.Z.HAEGGSTROM REMARK 1 TITL LEUKOTRIENE A4 HYDROLASE: IDENTIFICATION OF A COMMON REMARK 1 TITL 2 CARBOXYLATE RECOGNITION SITE FOR THE EPOXIDE HYDROLASE AND REMARK 1 TITL 3 AMINOPEPTIDASE SUBSTRATES REMARK 1 REF J.MOL.BIOL. V. 279 27376 2004 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 36768 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1704 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2636 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.78 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE SET COUNT : 142 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4877 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.22000 REMARK 3 B22 (A**2) : 1.15000 REMARK 3 B33 (A**2) : -0.93000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.268 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.226 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.165 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.496 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5029 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4510 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6831 ; 1.405 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10543 ; 0.851 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 609 ; 6.501 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 758 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5522 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1004 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1168 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5378 ; 0.231 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2762 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 336 ; 0.205 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.124 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.385 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 18 ; 0.250 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 16 ; 0.375 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3055 ; 0.711 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4963 ; 1.293 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1974 ; 1.726 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1868 ; 2.773 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3CHR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046790. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I711 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.091 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38521 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 17.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07100 REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.32800 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, SODIUM ACETATE, IMIDEAZOLE REMARK 280 PH 6.8, YBCL2, BESTATIN, LIQUID DIFFUSION, TEMPERATURE 298K, PH REMARK 280 8.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 33.67300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.60500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.67300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.60500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 642 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 699 O HOH A 938 2.00 REMARK 500 O HOH A 669 O HOH A 727 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 804 O HOH A 836 2565 1.76 REMARK 500 O HOH A 719 O HOH A 825 4557 2.12 REMARK 500 O HOH A 825 O HOH A 950 4457 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 5 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP A 55 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP A 183 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 371 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP A 422 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP A 426 CB - CG - OD2 ANGL. DEV. = 8.2 DEGREES REMARK 500 ASP A 481 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 482 CB - CG - OD2 ANGL. DEV. = 7.7 DEGREES REMARK 500 ASP A 549 CB - CG - OD2 ANGL. DEV. = 8.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 80 -138.58 79.27 REMARK 500 ASN A 97 -4.53 60.99 REMARK 500 LYS A 126 -8.19 74.01 REMARK 500 GLN A 134 87.53 -167.51 REMARK 500 ARG A 141 -9.94 -46.12 REMARK 500 ASP A 148 57.86 -95.01 REMARK 500 PRO A 163 133.15 -35.38 REMARK 500 ASP A 175 43.00 -107.31 REMARK 500 PRO A 184 -177.88 -53.89 REMARK 500 SER A 185 -6.37 78.27 REMARK 500 SER A 222 -159.80 -155.62 REMARK 500 LYS A 224 -53.46 -19.28 REMARK 500 GLU A 271 49.51 -84.45 REMARK 500 CYS A 274 -16.54 73.86 REMARK 500 ASP A 286 19.55 -149.50 REMARK 500 SER A 379 -174.99 -171.73 REMARK 500 PHE A 432 45.20 -100.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 611 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 295 NE2 REMARK 620 2 HIS A 299 NE2 102.1 REMARK 620 3 GLU A 318 OE1 102.4 107.8 REMARK 620 4 HOH A 627 O 92.9 123.7 121.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 611 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YB A 612 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4BS A 613 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 614 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HS6 RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN REMARK 900 RELATED ID: 1GW6 RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT REMARK 900 RELATED ID: 1H19 RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE E271Q MUTANT REMARK 900 RELATED ID: 1SQM RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE R563A MUTANT REMARK 900 RELATED ID: 3CHO RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH 2-AMINO-N-[4- REMARK 900 (PHENYLMETHOXY)PHENYL]-ACETAMIDE REMARK 900 RELATED ID: 3CHP RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH (3S)-3-AMINO- REMARK 900 4-OXO-4-[(4-PHENYLMETHOXYPHENYL)AMINO]BUTANOIC ACID REMARK 900 RELATED ID: 3CHQ RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH N5-[4- REMARK 900 (PHENYLMETHOXY)PHENYL]-L-GLUTAMINE REMARK 900 RELATED ID: 3CHS RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH (2S)-2-AMINO- REMARK 900 5-[[4-[(2S)-2-HYDROXY-2-PHENYL-ETHOXY]PHENYL]AMINO]-5-OXO-PENTANOIC REMARK 900 ACID REMARK 900 RELATED ID: 2VJ8 RELATED DB: PDB REMARK 900 STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH HYDROXAMIC REMARK 900 ACID BASED INHIBITOR DBREF 3CHR A 1 610 UNP P09960 LKHA4_HUMAN 2 611 SEQRES 1 A 610 PRO GLU ILE VAL ASP THR CYS SER LEU ALA SER PRO ALA SEQRES 2 A 610 SER VAL CYS ARG THR LYS HIS LEU HIS LEU ARG CYS SER SEQRES 3 A 610 VAL ASP PHE THR ARG ARG THR LEU THR GLY THR ALA ALA SEQRES 4 A 610 LEU THR VAL GLN SER GLN GLU ASP ASN LEU ARG SER LEU SEQRES 5 A 610 VAL LEU ASP THR LYS ASP LEU THR ILE GLU LYS VAL VAL SEQRES 6 A 610 ILE ASN GLY GLN GLU VAL LYS TYR ALA LEU GLY GLU ARG SEQRES 7 A 610 GLN SER TYR LYS GLY SER PRO MET GLU ILE SER LEU PRO SEQRES 8 A 610 ILE ALA LEU SER LYS ASN GLN GLU ILE VAL ILE GLU ILE SEQRES 9 A 610 SER PHE GLU THR SER PRO LYS SER SER ALA LEU GLN TRP SEQRES 10 A 610 LEU THR PRO GLU GLN THR SER GLY LYS GLU HIS PRO TYR SEQRES 11 A 610 LEU PHE SER GLN CYS GLN ALA ILE HIS CYS ARG ALA ILE SEQRES 12 A 610 LEU PRO CYS GLN ASP THR PRO SER VAL LYS LEU THR TYR SEQRES 13 A 610 THR ALA GLU VAL SER VAL PRO LYS GLU LEU VAL ALA LEU SEQRES 14 A 610 MET SER ALA ILE ARG ASP GLY GLU THR PRO ASP PRO GLU SEQRES 15 A 610 ASP PRO SER ARG LYS ILE TYR LYS PHE ILE GLN LYS VAL SEQRES 16 A 610 PRO ILE PRO CYS TYR LEU ILE ALA LEU VAL VAL GLY ALA SEQRES 17 A 610 LEU GLU SER ARG GLN ILE GLY PRO ARG THR LEU VAL TRP SEQRES 18 A 610 SER GLU LYS GLU GLN VAL GLU LYS SER ALA TYR GLU PHE SEQRES 19 A 610 SER GLU THR GLU SER MET LEU LYS ILE ALA GLU ASP LEU SEQRES 20 A 610 GLY GLY PRO TYR VAL TRP GLY GLN TYR ASP LEU LEU VAL SEQRES 21 A 610 LEU PRO PRO SER PHE PRO TYR GLY GLY MET GLU ASN PRO SEQRES 22 A 610 CYS LEU THR PHE VAL THR PRO THR LEU LEU ALA GLY ASP SEQRES 23 A 610 LYS SER LEU SER ASN VAL ILE ALA HIS GLU ILE SER HIS SEQRES 24 A 610 SER TRP THR GLY ASN LEU VAL THR ASN LYS THR TRP ASP SEQRES 25 A 610 HIS PHE TRP LEU ASN GLU GLY HIS THR VAL TYR LEU GLU SEQRES 26 A 610 ARG HIS ILE CYS GLY ARG LEU PHE GLY GLU LYS PHE ARG SEQRES 27 A 610 HIS PHE ASN ALA LEU GLY GLY TRP GLY GLU LEU GLN ASN SEQRES 28 A 610 SER VAL LYS THR PHE GLY GLU THR HIS PRO PHE THR LYS SEQRES 29 A 610 LEU VAL VAL ASP LEU THR ASP ILE ASP PRO ASP VAL ALA SEQRES 30 A 610 TYR SER SER VAL PRO TYR GLU LYS GLY PHE ALA LEU LEU SEQRES 31 A 610 PHE TYR LEU GLU GLN LEU LEU GLY GLY PRO GLU ILE PHE SEQRES 32 A 610 LEU GLY PHE LEU LYS ALA TYR VAL GLU LYS PHE SER TYR SEQRES 33 A 610 LYS SER ILE THR THR ASP ASP TRP LYS ASP PHE LEU TYR SEQRES 34 A 610 SER TYR PHE LYS ASP LYS VAL ASP VAL LEU ASN GLN VAL SEQRES 35 A 610 ASP TRP ASN ALA TRP LEU TYR SER PRO GLY LEU PRO PRO SEQRES 36 A 610 ILE LYS PRO ASN TYR ASP MET THR LEU THR ASN ALA CYS SEQRES 37 A 610 ILE ALA LEU SER GLN ARG TRP ILE THR ALA LYS GLU ASP SEQRES 38 A 610 ASP LEU ASN SER PHE ASN ALA THR ASP LEU LYS ASP LEU SEQRES 39 A 610 SER SER HIS GLN LEU ASN GLU PHE LEU ALA GLN THR LEU SEQRES 40 A 610 GLN ARG ALA PRO LEU PRO LEU GLY HIS ILE LYS ARG MET SEQRES 41 A 610 GLN GLU VAL TYR ASN PHE ASN ALA ILE ASN ASN SER GLU SEQRES 42 A 610 ILE ARG PHE ARG TRP LEU ARG LEU CYS ILE GLN SER LYS SEQRES 43 A 610 TRP GLU ASP ALA ILE PRO LEU ALA LEU LYS MET ALA THR SEQRES 44 A 610 GLU GLN GLY ARG MET LYS PHE THR ARG PRO LEU PHE LYS SEQRES 45 A 610 ASP LEU ALA ALA PHE ASP LYS SER HIS ASP GLN ALA VAL SEQRES 46 A 610 ARG THR TYR GLN GLU HIS LYS ALA SER MET HIS PRO VAL SEQRES 47 A 610 THR ALA MET LEU VAL GLY LYS ASP LEU LYS VAL ASP HET ZN A 611 1 HET YB A 612 1 HET 4BS A 613 21 HET IMD A 614 5 HETNAM ZN ZINC ION HETNAM YB YTTERBIUM (III) ION HETNAM 4BS 4-AMINO-N-[4-(BENZYLOXY)PHENYL]BUTANAMIDE HETNAM IMD IMIDAZOLE FORMUL 2 ZN ZN 2+ FORMUL 3 YB YB 3+ FORMUL 4 4BS C17 H20 N2 O2 FORMUL 5 IMD C3 H5 N2 1+ FORMUL 6 HOH *360(H2 O) HELIX 1 1 GLN A 79 GLY A 83 5 5 HELIX 2 2 THR A 119 THR A 123 5 5 HELIX 3 3 HIS A 139 ILE A 143 5 5 HELIX 4 4 PRO A 198 ILE A 202 5 5 HELIX 5 5 GLU A 223 PHE A 234 1 12 HELIX 6 6 GLU A 236 GLY A 249 1 14 HELIX 7 7 PRO A 280 LEU A 283 5 4 HELIX 8 8 SER A 290 SER A 300 1 11 HELIX 9 9 THR A 310 HIS A 313 5 4 HELIX 10 10 PHE A 314 GLY A 334 1 21 HELIX 11 11 GLY A 334 GLY A 357 1 24 HELIX 12 12 HIS A 360 LYS A 364 5 5 HELIX 13 13 ASP A 373 TYR A 378 1 6 HELIX 14 14 SER A 380 LEU A 397 1 18 HELIX 15 15 GLY A 399 SER A 415 1 17 HELIX 16 16 THR A 420 PHE A 432 1 13 HELIX 17 17 LYS A 435 ASN A 440 1 6 HELIX 18 18 ASP A 443 SER A 450 1 8 HELIX 19 19 THR A 465 ALA A 478 1 14 HELIX 20 20 LYS A 479 LEU A 483 5 5 HELIX 21 21 ASN A 487 LYS A 492 5 6 HELIX 22 22 SER A 495 GLN A 508 1 14 HELIX 23 23 PRO A 513 ASN A 525 1 13 HELIX 24 24 PHE A 526 ILE A 529 5 4 HELIX 25 25 ASN A 531 SER A 545 1 15 HELIX 26 26 ASP A 549 GLN A 561 1 13 HELIX 27 27 ARG A 563 PHE A 577 1 15 HELIX 28 28 SER A 580 LYS A 592 1 13 HELIX 29 29 HIS A 596 LEU A 607 1 12 SHEET 1 A 8 GLN A 69 GLU A 70 0 SHEET 2 A 8 LEU A 59 ILE A 66 -1 N ILE A 66 O GLN A 69 SHEET 3 A 8 GLU A 99 THR A 108 -1 O SER A 105 N LYS A 63 SHEET 4 A 8 THR A 33 SER A 44 -1 N VAL A 42 O ILE A 100 SHEET 5 A 8 CYS A 16 ASP A 28 -1 N ARG A 24 O THR A 37 SHEET 6 A 8 LEU A 154 PRO A 163 1 O GLU A 159 N LEU A 23 SHEET 7 A 8 ARG A 186 ILE A 197 -1 O PHE A 191 N ALA A 158 SHEET 8 A 8 ILE A 173 PRO A 179 -1 N ASP A 175 O LYS A 190 SHEET 1 B 3 LEU A 49 THR A 56 0 SHEET 2 B 3 SER A 84 LEU A 94 -1 O LEU A 94 N LEU A 49 SHEET 3 B 3 TYR A 73 LEU A 75 -1 N ALA A 74 O GLU A 87 SHEET 1 C 4 LEU A 115 LEU A 118 0 SHEET 2 C 4 TYR A 130 SER A 133 -1 O TYR A 130 N LEU A 118 SHEET 3 C 4 LEU A 204 GLY A 207 -1 O VAL A 206 N LEU A 131 SHEET 4 C 4 VAL A 167 MET A 170 -1 N VAL A 167 O GLY A 207 SHEET 1 D 5 GLU A 210 GLY A 215 0 SHEET 2 D 5 THR A 218 SER A 222 -1 O SER A 222 N GLU A 210 SHEET 3 D 5 ASP A 257 VAL A 260 1 O LEU A 258 N TRP A 221 SHEET 4 D 5 LEU A 275 VAL A 278 1 O THR A 276 N LEU A 259 SHEET 5 D 5 GLY A 269 MET A 270 -1 N MET A 270 O PHE A 277 SHEET 1 E 2 VAL A 306 ASN A 308 0 SHEET 2 E 2 LYS A 417 ILE A 419 1 O ILE A 419 N THR A 307 LINK NE2 HIS A 295 ZN ZN A 611 1555 1555 1.99 LINK NE2 HIS A 299 ZN ZN A 611 1555 1555 2.10 LINK OE1 GLU A 318 ZN ZN A 611 1555 1555 1.86 LINK OD2 ASP A 426 YB YB A 612 1555 4457 2.01 LINK ZN ZN A 611 O HOH A 627 1555 1555 2.35 CISPEP 1 GLN A 136 ALA A 137 0 8.36 CISPEP 2 ALA A 510 PRO A 511 0 2.72 SITE 1 AC1 4 HIS A 295 HIS A 299 GLU A 318 HOH A 627 SITE 1 AC2 5 ASP A 422 ASP A 426 ASP A 481 HOH A 631 SITE 2 AC2 5 HOH A 749 SITE 1 AC3 9 GLN A 136 GLY A 269 GLU A 271 TRP A 311 SITE 2 AC3 9 PHE A 314 GLU A 318 PRO A 374 ALA A 377 SITE 3 AC3 9 TYR A 378 SITE 1 AC4 6 GLY A 344 GLY A 347 GLU A 348 GLU A 501 SITE 2 AC4 6 ALA A 504 GLN A 508 CRYST1 67.346 133.210 83.100 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014849 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007507 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012034 0.00000